- NEWS FEATURE
Dozens of new obesity drugs are coming: these are the ones to watch
Illustration: Zofia Chamienia
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 638, 308-310 (2025)
doi: https://doi.org/10.1038/d41586-025-00404-9
References
Jastreboff, A. M. et al. N. Engl. J. Med. 389, 514–526 (2023).
Wharton, S. et al. N. Engl. J. Med. 389, 877–888 (2023).
Akbari, P. et al. Science 373, eabf8683 (2021).
Deaton, A. M. et al. Nature Commun. 13, 4319 (2022).
Prado, C. M., Phillips, S. M., Gonzalez, M. C. & Heymsfield, S. B. Lancet Diabetes Endocrinol. 12, 785–787 (2024).
Conte, C., Hall, K. D. & Klein, S. JAMA 332, 9–10 (2024).
Obesity drugs: huge study identifies new health risks
Why do obesity drugs seem to treat so many other ailments?
How ‘miracle’ weight-loss drugs will change the world